Neither delta-8 THC nor CBD is universally “better” for pain. They work through completely different mechanisms, and the right choice depends on the type of pain you’re dealing with, whether you can tolerate a high, and what other medications you take. Delta-8 produces a mild psychoactive effect and activates the same receptors as regular THC, making it more similar to a traditional cannabis experience. CBD is non-intoxicating and works primarily through anti-inflammatory pathways. Here’s how they compare in practical terms.
How Each One Works in the Body
Delta-8 THC binds directly to the cannabinoid receptors in your brain and immune system, the same ones that regular (delta-9) THC targets. Lab data published in the British Journal of Pharmacology show that delta-8’s binding strength at these receptors is roughly comparable to delta-9 THC, with values in the 44 to 48 nanomolar range at the CB1 receptor versus 5 to 80 nanomolar for delta-9 depending on the study. In plain terms, delta-8 activates the same pain-dampening system that marijuana does, just with a somewhat milder psychoactive punch.
CBD takes a different route entirely. Instead of locking onto cannabinoid receptors, it activates serotonin receptors and a pain-sensing ion channel called TRPV1. The serotonin activity helps modulate how your nervous system interprets pain signals, while TRPV1 activation can desensitize nerve endings over time, reducing their reactivity. This is the same channel that capsaicin (the heat in chili peppers) targets, which is why capsaicin creams are used for pain relief. CBD essentially borrows that same biological trick without the burning sensation.
Inflammatory Pain: Where CBD Has an Edge
If your pain stems from inflammation, such as arthritis, tendinitis, or autoimmune flare-ups, CBD has the stronger evidence base. Research shows that CBD significantly suppresses the secretion of TNF-alpha, one of the main inflammatory signaling molecules your immune cells produce. In one study, CBD decreased the secretion of 20 different inflammatory cytokines and chemokines by shifting immune cells away from their pro-inflammatory state. This is a broad anti-inflammatory effect, not just pain masking.
A clinical trial of topical CBD gel for thumb osteoarthritis found that patients’ pain scores dropped from 5.0 to 2.2 on a 10-point visual scale, compared to a drop from 4.9 to only 4.0 with a placebo gel. That’s roughly a 56% reduction in pain for the CBD group versus 18% for placebo. For localized joint or muscle pain, topical CBD can deliver meaningful relief right where you need it.
Delta-8 can also reduce the perception of inflammatory pain, but it does so mainly by altering how your brain processes pain signals rather than by calming inflammation at its source. If reducing the underlying inflammation matters to you (and it usually should), CBD addresses the cause more directly.
Nerve Pain and General Chronic Pain
For neuropathic pain, the picture is less clear-cut. Delta-8’s direct activation of cannabinoid receptors in the brain and spinal cord can be effective at dulling nerve pain, and anecdotal reports from users frequently cite this as their primary reason for choosing it. THC-type compounds have a longer track record for nerve pain than CBD alone.
One clinical trial using inhaled cannabis containing both THC and CBD found that 67% of patients experienced pain relief and 35% had complete pain elimination within two hours, with effects lasting up to 48 hours. However, that study used a combination product, not delta-8 specifically. A separate study comparing CBD spray alone to a THC/CBD combination for chronic pain found CBD was slightly less effective on its own, though the difference wasn’t dramatic. The CBD dose in that trial was only 22.5 mg per day, which is on the low end.
The practical takeaway: for nerve pain or widespread chronic pain, a THC-type compound like delta-8 may provide faster, more noticeable relief. CBD may still help, but it often works better as part of a broader approach or in combination with other treatments.
The Psychoactive Factor
Delta-8 gets you high. It’s a milder high than delta-9 THC, often described as more clear-headed and less anxious, but it is still psychoactive. For some people dealing with chronic pain, that mood lift is part of the appeal. For others, especially those who need to work, drive, or stay sharp, it’s a dealbreaker.
CBD produces no intoxication at any dose. You can take it before a meeting, before driving, or before bed without cognitive impairment. If you need daytime pain management without any mental fog, CBD is the obvious choice. Some people use both: CBD during the day and delta-8 in the evening when impairment matters less.
Drug Interactions Worth Knowing About
Both compounds interfere with your liver’s ability to break down other medications, but they do so in different ways and to different degrees.
CBD is a potent inhibitor of several liver enzymes, particularly those that metabolize common drugs like blood thinners (warfarin), certain antidepressants, and proton pump inhibitors. If you take prescription medications daily, CBD can raise their levels in your blood, sometimes significantly.
Delta-8 poses its own interaction risks, particularly with anti-inflammatory drugs. A 2025 study in Drug Metabolism and Disposition found that a 10 mg oral dose of delta-8 could increase your body’s exposure to diclofenac (a common prescription anti-inflammatory) by at least 119%. At 40 mg of delta-8, that number jumped to 348%. Delta-8 also increased warfarin exposure by at least 61% at 10 mg and 205% at 40 mg. These aren’t trivial numbers. If you take NSAIDs regularly for pain or use a blood thinner, oral delta-8 could push those drugs to potentially dangerous levels. Inhaled delta-8 posed minimal interaction risk at typical doses, likely because less of the compound passes through the liver.
Dosing Differences
CBD doses used in pain studies vary widely. For chronic pain, research has used doses as low as 10 to 22.5 mg per day with measurable results. Many commercial products suggest 25 to 50 mg daily, which falls in a reasonable range based on available clinical data. Higher doses (100 mg and above) are sometimes used for severe pain or anxiety, but the relationship between dose and effect isn’t perfectly linear. Starting low and increasing gradually over a week or two is the standard approach.
Delta-8 dosing is harder to pin down because there’s far less clinical research. Most users report effective doses between 10 and 40 mg, but tolerance builds quickly with regular use. Products vary enormously in actual delta-8 content, and independent lab testing has found that many products don’t match their labels.
Legal Status Is Shifting Fast
CBD derived from hemp (containing less than 0.3% delta-9 THC) is legal federally and available in all 50 states. Its legal status is stable and unlikely to change.
Delta-8 is in a very different position. It proliferated through a loophole in the 2018 Farm Bill, which only set limits on delta-9 THC. That loophole is closing. A provision inserted into the November 2025 government spending deal outlaws hemp-derived products containing synthetic or semi-synthetic cannabinoids like delta-8, as well as any hemp product with more than 0.4 milligrams of THC. This ban is set to take effect in November 2026. The 2026 Farm Bill is also redefining hemp using a total THC threshold rather than a delta-9-only limit. Multiple states have already banned delta-8 independently. If you’re considering delta-8 for long-term pain management, its availability may not last.
Choosing Between Them
For inflammatory conditions like arthritis, CBD’s direct anti-inflammatory action and strong safety profile make it the more practical first choice. For nerve pain or pain that hasn’t responded to other treatments, delta-8’s stronger receptor activation may offer more noticeable relief, but it comes with psychoactive effects, less regulatory oversight, and growing legal uncertainty. The FDA has flagged serious health concerns about delta-8 products specifically, partly because manufacturing often involves chemical conversion from CBD using solvents and acids, which can leave harmful byproducts if not properly purified.
If you’re already taking anti-inflammatory medications or blood thinners, both compounds require caution, but delta-8’s interactions with common NSAIDs are particularly pronounced at oral doses. Whichever you choose, look for products with third-party lab certificates showing both cannabinoid content and contaminant testing. The unregulated nature of both markets means quality varies dramatically from brand to brand.